by Proactive LTC Consulting | Feb 6, 2023 | Abuse, Blog, Compliance, Falls, Legal, Regulatory, Uncategorized
Every incident, whether it involves a crime, an accident, or a natural disaster, leaves traces of evidence at the scene. The goal of every investigation is to correctly identify the facts, reconstruct the events and deduce what occurred. When possible illegal... by Proactive LTC Consulting | Nov 1, 2022 | CMS, Quality, Regulatory, Uncategorized
On Oct. 21, 2022, CMS issued QSO-23-01-NH, announcing revisions to the Special Focus Facility (SFF) program with an emphasis on improving the quality of care that residents living in SFF receive. The changes to the program aim to address facilities that remain in the... by Proactive LTC Consulting | Sep 13, 2021 | 5-Star, Blog, Compliance, Falls, Nursing, QAPI, Quality, Regulatory, SNF, Survey
F689 Free of Accident Hazards/Supervision/Devices has been the third most frequently cited F tag so far in the 2021 fiscal year per Casper data (9/5/21). 3,466 citations have been issued nationally for the 16.6% of providers surveyed. Scope and Severity has ranged... by Proactive LTC Consulting | Sep 8, 2021 | 5-Star, Blog, Nursing, Quality Measure, Regulatory
The prevalence of pain in long-term care residents is estimated to range from 49% to 83%” (Fox, Raina, & Jadad, 1999). Chronic pain is the top cause of long-term disability in the US, and advanced age a key indicator of chronic pain risk (Ljubica Cvetkovska).... by Proactive LTC Consulting | Aug 25, 2021 | Blog, MDS, Quality, Regulatory, Survey
Care planning is an essential part of quality patient care as it offers an organized structure of identification of needs via the comprehensive assessment. This structure then drives the individualized type of services and care the resident receives by the development... by Proactive LTC Consulting | Aug 16, 2021 | 5-Star, Blog, Nursing, Regulatory, Survey
F761 Label/Store Drugs and Biologicals is currently the 8th most frequently cited deficiency throughout the nation thus far in FY2021. Source: CASPER 08/08/2021 REGULATION The F761 regulation includes three requirements: Labeling – (1) Drugs and biologicals...